Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
NIH/NIDDK (RO1-DK133520)
- License Information
-
More Information
Article History
Accepted: 14 March 2023
First Online: 17 April 2023
Compliance with Ethical Standards
:
: AS served on the advisory board for Phathom Pharmaceuticals, Takeda Pharmaceuticals, Salix Pharmaceuticals, and Ironwood Pharmaceuticals. He has received research funding from Vibrant Ltd, Parkinson’s Foundation, and NIDDK.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
